Connection
KatherineL Frasca to Anti-HIV Agents
This is a "connection" page, showing publications KatherineL Frasca has written about Anti-HIV Agents.
|
|
Connection Strength |
|
 |
|
 |
|
1.378 |
|
|
|
-
Goodman A, Patten L, Castillo-Mancilla J, Zimmer S, Madinger N, Frasca K. Factors Associated with Retention and Adherence in a Comprehensive, Diverse HIV Pre-Exposure Prophylaxis Clinic. AIDS Res Hum Retroviruses. 2022 04; 38(4):327-335.
Score: 0.504
-
Frasca K, Morrow M, Coyle RP, Coleman SS, Ellison L, Bushman LR, Kiser JJ, Zheng JH, Mawhinney S, Anderson PL, Castillo-Mancilla J. Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy. J Antimicrob Chemother. 2019 05 01; 74(5):1395-1401.
Score: 0.418
-
Frasca K, Fisher RG, McGuire E. Alternative dosage of zidovudine in infants exposed to maternal human immunodeficiency virus infection. Pediatr Infect Dis J. 2009 Dec; 28(12):1131-2.
Score: 0.218
-
Bonacci RA, Frasca K, Swift L, Sha D, Bilker WB, Bamford L, Yehia BR, Gross R. Antiretroviral Refill Adherence Correlates with, But Poorly Predicts Retention in HIV Care. AIDS Behav. 2016 05; 20(5):1060-7.
Score: 0.085
-
Frasca K, Cohn J. Integration of HIV and tuberculosis in the community. J Int Assoc Provid AIDS Care. 2014 Nov-Dec; 13(6):534-8.
Score: 0.077
-
Frasca K, Cohn J. Integration of HIV and tuberculosis in the community. J Int Assoc Provid AIDS Care. 2014 Nov-Dec; 13(6):534-8.
Score: 0.077
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|